Ruijin Hospital: Pancreatic Neoplasms trials

The registry lists 21 Pancreatic Neoplasms studies with Ruijin Hospital as lead sponsor. 13 are open to participants now and 0 have results posted.

Early Phase 1 4Phase 2 7Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic CancerNot yet recruitingNCT07745790Phase 2
• A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic CancerRecruitingNCT07649928Early Phase 1
• Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET ImagingNot yet recruitingNCT07554742
• Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver MetastasesRecruitingNCT07504471Phase 2
• HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic CancerRecruitingNCT07131514Phase 2
• Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic CancerNot yet recruitingNCT06677762
• The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.RecruitingNCT06601010
• HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic CancerRecruitingNCT06587061Phase 2
• Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid TumorsRecruitingNCT06577532Early Phase 1
• Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic CancerRecruitingNCT06496373Early Phase 1
• Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic DiseasesRecruitingNCT05193162
• SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic CancerNot yet recruitingNCT05185869Phase 2
• Microbial Diversity of Pancreatic DiseasesRecruitingNCT03809247
• Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic CancerCompletedNCT06538623Phase 2
• A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic CancerCompletedNCT06363084
• TCR-T Cells in the Treatment of Advanced Pancreatic CancerStatus unknownNCT06054984Early Phase 1
• Radiomics in Pancreatic CancerStatus unknownNCT05658679
• Comparsion of WT and SNP Techniques of EUS-FNB in Pancreatic Solid Mass (WESP-PSM)Status unknownNCT04605042Not applicable
• Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary TumorsCompletedNCT04400357Not applicable
• Metronomic Chemotherapy With Capecitabine for Pancreatic CancerStatus unknownNCT03959150Phase 2/3
• Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic CancerStatus unknownNCT03882866Not applicable